| dopamine receptor D4 |
EUCALYPTOL |
Dopamine D4.2 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
ETIDRONATE |
Serotonin 5-HT1A |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
ETIDRONATE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
ETIDRONATE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor, beta 2 |
FELODIPINE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| bradykinin receptor B2 |
FELODIPINE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
FAMCICLOVIR |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D1A |
EUCALYPTOL |
Dopamine D1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
FELODIPINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
FELODIPINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
GENISTEIN |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
GENTIAN VIOLET |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
GENTIAN VIOLET |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
LACTIC ACID |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| interleukin 8 receptor, alpha |
GENTIAN VIOLET |
Chemokine CXCR1(IL-8A) |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
TRAZODONE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
TRAZODONE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
IDOXURIDINE |
Protein Serine/Threonine Kinase, ERK2 |
-18% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
PYRAZINAMIDE |
Protein Tyrosine Kinase, HER2 Receptor |
-18% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
PYRAZINAMIDE |
Protein Tyrosine Kinase, HER2 Receptor |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
LEVOCARNITINE |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
LEVOCARNITINE |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 1 |
ARTEMETHER |
Histamine H1, Central |
-18% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 |
KETAMINE |
Thromboxane Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
KETAMINE |
Thromboxane Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
FLUBENDAZOLE |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
FLUBENDAZOLE |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, NMDA2C |
FLUBENDAZOLE |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
FLUBENDAZOLE |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
FLUBENDAZOLE |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
FLUBENDAZOLE |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase (YT blood group) |
SALINOMYCIN |
Acetylcholinesterase |
-18% |
NoneNone |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
SALINOMYCIN |
Acetylcholinesterase |
-18% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase |
SALINOMYCIN |
Acetylcholinesterase |
-18% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 2 |
PYRAZINAMIDE |
Histamine H2 |
-18% |
NoneNone |
NoneNone |
View
|
| platelet-activating factor receptor |
ROFECOXIB |
Platelet Activating Factor (PAF) |
-18% |
NoneNone |
NoneNone |
View
|
| endothelin receptor type A |
PHYSOSTIGMINE |
Endothelin ETA |
-18% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
PYRAZINAMIDE |
CYP450-1A2 Inhibition |
-18% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
DIGOXIN |
Serotonin 5-HT6 |
-18% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 2 |
TERFENADINE |
Adrenergic beta2 |
-18% |
NoneNone |
NoneNone |
View
|
| interleukin 1 receptor, type I |
COUMARIN |
Interleukin IL-1 alpha |
-18% |
NoneNone |
NoneNone |
View
|
| endothelin receptor type A |
PIRACETAM |
Endothelin ETA |
-18% |
NoneNone |
NoneNone |
View
|
| natriuretic peptide receptor 2 |
MADURAMICIN |
Atrial Natriuretic Factor (ANF) |
-18% |
NoneNone |
NoneNone |
View
|
| guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
MADURAMICIN |
Atrial Natriuretic Factor (ANF) |
-18% |
NoneNone |
NoneNone |
View
|
| natriuretic peptide receptor 3 |
MADURAMICIN |
Atrial Natriuretic Factor (ANF) |
-18% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
NIFLUMIC ACID |
Muscarinic M1 |
-18% |
NoneNone |
NoneNone |
View
|
| opioid receptor, sigma 1 |
PIRACETAM |
Sigma1 |
-18% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
PROPYLENE GLYCOL |
Protein Tyrosine Kinase, HER2 Receptor |
-18% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
PROPYLENE GLYCOL |
Protein Tyrosine Kinase, HER2 Receptor |
-18% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
RITONAVIR |
Adrenergic alpha2B |
-18% |
NoneNone |
NoneNone |
View
|
| interleukin 1 receptor, type I |
NEOSTIGMINE BROMIDE |
Interleukin IL-1 alpha |
-18% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
STANNOUS FLUORIDE |
CYP450-1A2 Inhibition |
-18% |
NoneNone |
NoneNone |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
NEOSTIGMINE BROMIDE |
Glucocorticoid |
-18% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
SODIUM ARSENITE |
Leukotriene C4 Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
SODIUM ARSENITE |
Leukotriene C4 Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
EUCALYPTOL |
CYP450-2C19 Inhibition |
-18% |
NoneNone |
NoneNone |
View
|
| tachykinin receptor 1 |
OXYMETAZOLINE |
Tachykinin NK1 |
-18% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
OXYMETAZOLINE |
Protein Tyrosine Kinase, HER2 Receptor |
-18% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
OXYMETAZOLINE |
Protein Tyrosine Kinase, HER2 Receptor |
-18% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D3 |
SECNIDAZOLE |
Dopamine D3 |
-18% |
NoneNone |
NoneNone |
View
|
| adenosine A2a receptor |
ALPHA-CYCLODEXTRIN |
Adenosine A2A |
-18% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D1A |
ACEBUTOLOL |
Dopamine D1 |
-18% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 |
4-FLUORO-L-PHENYLALANINE |
Thromboxane Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
4-FLUORO-L-PHENYLALANINE |
Thromboxane Synthetase |
-18% |
NoneNone |
NoneNone |
View
|
| neuropeptide Y receptor Y1 |
ONDANSETRON |
Neuropeptide Y1 |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
SECNIDAZOLE |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
SECNIDAZOLE |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
| adenosine A2a receptor |
EBASTINE |
Adenosine A2A |
-18% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
PHENYLHYDRAZINE |
Serotonin 5-HT2B |
-18% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
POLYVINYLPYRROLIDONE |
Adrenergic, Norepinephrine Transporter |
-18% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
CADMIUM CHLORIDE |
Serotonin 5-HT1B |
-18% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
PRIMAQUINE |
Progesterone |
-18% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
PRIMAQUINE |
Progesterone |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CINNAMALDEHYDE |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CINNAMALDEHYDE |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CINNAMALDEHYDE |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CINNAMALDEHYDE |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CINNAMALDEHYDE |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CINNAMALDEHYDE |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CINNAMALDEHYDE |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 1 |
TRIMETHADIONE |
Purinergic P2X |
-18% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 7 |
TRIMETHADIONE |
Purinergic P2X |
-18% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X-like 1, orphan receptor |
TRIMETHADIONE |
Purinergic P2X |
-18% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 2 |
BETAMETHASONE PHOSPHATE |
Histamine H2 |
-18% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
BENZYL ALCOHOL |
Chemokine CCR5 |
-18% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3B |
YOHIMBINE |
Phosphodiesterase PDE3 |
-18% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3A |
YOHIMBINE |
Phosphodiesterase PDE3 |
-18% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 5 |
TAZOBACTAM |
Muscarinic M5 |
-18% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
TERBUTALINE |
Insulin |
-18% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
TERBUTALINE |
Insulin |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DIGITOXIN |
Calcium Channel Type L, Phenylalkylamine |
-18% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
(RS)-AMPA |
Protein Serine/Threonine Kinase PKCalpha |
-18% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
(RS)-AMPA |
Protein Serine/Threonine Kinase PKCalpha |
-18% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 3 |
(RS)-AMPA |
Adrenergic beta3 |
-18% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
BETAHISTINE |
Serotonin 5-HT2B |
-18% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 4 polypeptide |
TAZOBACTAM |
ATPase, Na+/K+ |
-18% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 3 polypeptide |
TAZOBACTAM |
ATPase, Na+/K+ |
-18% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 2 polypeptide |
TAZOBACTAM |
ATPase, Na+/K+ |
-18% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 1 polypeptide |
TAZOBACTAM |
ATPase, Na+/K+ |
-18% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 1 polypeptide |
TAZOBACTAM |
ATPase, Na+/K+ |
-18% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 3 polypeptide |
TAZOBACTAM |
ATPase, Na+/K+ |
-18% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 2 polypeptide |
TAZOBACTAM |
ATPase, Na+/K+ |
-18% |
NoneNone |
NoneNone |
View
|
| ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
TAZOBACTAM |
ATPase, Na+/K+ |
-18% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
NIFEDIPINE |
beta-Lactamase |
-18% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
HOMATROPINE HYDROBROMIDE |
CYP450-1A2 Inhibition |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, AMPA1 (alpha 1) |
NIFEDIPINE |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, AMPA2 |
NIFEDIPINE |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, AMPA3 (alpha 3) |
NIFEDIPINE |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
BETA CYCLODEXTRIN |
Calcium Channel Type L, Benzothiazepine |
-18% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 3 |
LORAZEPAM |
Adrenergic beta3 |
-18% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
TRICHLORMETHIAZIDE |
Adrenergic alpha2A |
-18% |
NoneNone |
NoneNone |
View
|
| platelet-activating factor receptor |
TROGLITAZONE |
Platelet Activating Factor (PAF) |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 5 (DBSS) |
KETOPROFEN |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1b |
KETOPROFEN |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1a |
KETOPROFEN |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 4 |
KETOPROFEN |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
KETOPROFEN |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 8 |
KETOPROFEN |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 2 |
(-)-THALIDOMIDE |
Histamine H2 |
-18% |
NoneNone |
NoneNone |
View
|
| interleukin 8 receptor, alpha |
4-AMINO-1,8-NAPHTHALIMIDE |
Chemokine CXCR1(IL-8A) |
-18% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D1A |
DEXIBUPROFEN |
Dopamine D1 |
-18% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
VECURONIUM BROMIDE |
Progesterone |
-18% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
VECURONIUM BROMIDE |
Progesterone |
-18% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 4 |
METYRAPONE |
Chemokine CCR4 |
-18% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
MILRINONE |
Cyclooxygenase COX-1 |
-18% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
BROMHEXINE |
Protein Serine/Threonine Kinase PKCalpha |
-18% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
BROMHEXINE |
Protein Serine/Threonine Kinase PKCalpha |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
CLONIDINE |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
CLONIDINE |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
| arginine vasopressin receptor 1A |
BUSPIRONE |
Vasopressin V1A |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, kainate 5 |
LOSARTAN |
Glutamate, Kainate |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, kainate 4 |
LOSARTAN |
Glutamate, Kainate |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, kainate 3 |
LOSARTAN |
Glutamate, Kainate |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, kainate 2 |
LOSARTAN |
Glutamate, Kainate |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, kainate 1 |
LOSARTAN |
Glutamate, Kainate |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
(S)-(-)-PINDOLOL |
Protein Serine/Threonine Kinase, ERK2 |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
(S)-(-)-PINDOLOL |
Protein Serine/Threonine Kinase, ERK2 |
-18% |
NoneNone |
NoneNone |
View
|
| cholecystokinin A receptor |
IVERMECTIN |
Cholecystokinin CCKA |
-18% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
BUTENAFINE |
Insulin |
-18% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
BUTENAFINE |
Insulin |
-18% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3B |
VALSARTAN |
Phosphodiesterase PDE3 |
-18% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3A |
VALSARTAN |
Phosphodiesterase PDE3 |
-18% |
NoneNone |
NoneNone |
View
|
| neuropeptide Y receptor Y1 |
CARBOPLATIN |
Neuropeptide Y1 |
-18% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
(S)-(-)-PINDOLOL |
Insulin |
-18% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
(S)-(-)-PINDOLOL |
Insulin |
-18% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
10,11-DIHYDRO-CARBAMAZEPINE |
Serotonin 5-HT1A |
-18% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
VALSARTAN |
Chemokine CCR5 |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
DIHYDROERGOCRISTINE MESYLATE |
Protein Serine/Threonine Kinase, p38alpha |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
DIHYDROERGOCRISTINE MESYLATE |
Protein Serine/Threonine Kinase, p38alpha |
-18% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
SPECTINOMYCIN |
Leukotriene B4 |
-19% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
SPECTINOMYCIN |
Leukotriene B4 |
-19% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
SPECTINOMYCIN |
Leukotriene B4 |
-19% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
MELPHALAN |
Protein Serine/Threonine Kinase, ERK1 |
-19% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
MELPHALAN |
Protein Serine/Threonine Kinase, ERK1 |
-19% |
NoneNone |
NoneNone |
View
|